An enhanced expression of STAT3 has been reported in recurrent ovarian tumours extracted from metastatic ovarian lesions and ascites-derived tumours, compared to primary tumours and chemonaive ascites-derived tumours [69, 70]. This evidence concerns the gene STAT3 and ovarian neoplasm.